Equitable Trust Co. Sells 432 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Equitable Trust Co. cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.7% during the 3rd quarter, Holdings Channel.com reports. The fund owned 3,248 shares of the medical equipment provider’s stock after selling 432 shares during the period. Equitable Trust Co.’s holdings in Intuitive Surgical were worth $1,596,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Creekmur Asset Management LLC lifted its position in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical during the 2nd quarter worth approximately $26,000. Delos Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 57 shares during the last quarter. Godsey & Gibb Inc. grew its holdings in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares in the last quarter. Finally, LRI Investments LLC purchased a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $482.21, for a total value of $90,655.48. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,655,048.26. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,655,048.26. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mark Brosius sold 2,115 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the sale, the insider now owns 295 shares of the company’s stock, valued at approximately $145,113.45. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 68,246 shares of company stock worth $33,839,308. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Up 2.3 %

Shares of ISRG opened at $536.45 on Friday. Intuitive Surgical, Inc. has a twelve month low of $269.49 and a twelve month high of $538.49. The stock has a market cap of $191.07 billion, a PE ratio of 86.25, a P/E/G ratio of 5.07 and a beta of 1.39. The business’s 50-day moving average price is $493.92 and its 200-day moving average price is $451.73.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. BTIG Research set a $535.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird boosted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, Citigroup raised their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.